Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.

Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q36060147

Q36060147

about

Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q36060147

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@ast

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@en

type

Item

label

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@ast

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@en

prefLabel

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@ast

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@en

P1476

Harmonizing Optimal Strategy f ...... a randomized controlled trial.

@en

P2093

Bon-Kwon Koo

http://www.w3.org/2001/XMLSchema#string

Dong-Bin Kim

http://www.w3.org/2001/XMLSchema#string

Eun-Seok Shin

http://www.w3.org/2001/XMLSchema#string

Han-Mo Yang

http://www.w3.org/2001/XMLSchema#string

Hyo-Soo Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Jae Kang

http://www.w3.org/2001/XMLSchema#string

In-Ho Chae

http://www.w3.org/2001/XMLSchema#string

Jang-Whan Bae

http://www.w3.org/2001/XMLSchema#string

Jay Young Rhew

http://www.w3.org/2001/XMLSchema#string

Ji-Hyun Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial

Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Clinical end points in coronary stent trials: a case for standardized definitions.

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

P2888

s13063-015-0925-5

P304

409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-015-0925-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282038392

http://www.w3.org/2001/XMLSchema#string

P6179

1046144609

http://www.w3.org/2001/XMLSchema#string

P698

26374625

http://www.w3.org/2001/XMLSchema#string

P932

4570043

http://www.w3.org/2001/XMLSchema#string

Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.

about

Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932